STeroids to REduce Systemic Inflammation After Infant Heart Surgery (STRESS)
STeroids to REduce Systemic Inflammation After Infant Heart Surgery (STRESS)
Sponsor: Kevin Hill
Listed as NCT03229538, this PHASE3 trial focuses on Congenital Heart Disease in Children and Inflammatory Response and remains completed. Sponsored by Kevin Hill, it has been updated 17 times since 2017, reflecting substantial change activity. This study contributes longitudinal data to the cardiovascular research landscape.
Status Flow
Change History
17 versions recorded-
Feb 2026 — Present [monthly]
Completed PHASE3
-
Sep 2025 — Feb 2026 [monthly]
Completed PHASE3
-
Sep 2024 — Sep 2025 [monthly]
Completed PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE3
-
Jun 2023 — Jul 2024 [monthly]
Completed PHASE3
▶ Show 12 earlier versions
-
Feb 2023 — Jun 2023 [monthly]
Completed PHASE3
-
Jul 2022 — Feb 2023 [monthly]
Completed PHASE3
Status: Active Not Recruiting → Completed
-
Apr 2022 — Jul 2022 [monthly]
Active Not Recruiting PHASE3
Status: Recruiting → Active Not Recruiting
-
Sep 2021 — Apr 2022 [monthly]
Recruiting PHASE3
-
Jan 2021 — Sep 2021 [monthly]
Recruiting PHASE3
-
Aug 2020 — Jan 2021 [monthly]
Recruiting PHASE3
-
Jul 2019 — Aug 2020 [monthly]
Recruiting PHASE3
-
Jan 2019 — Jul 2019 [monthly]
Recruiting PHASE3
-
Sep 2018 — Jan 2019 [monthly]
Recruiting PHASE3
-
Jun 2018 — Sep 2018 [monthly]
Recruiting PHASE3
-
Nov 2017 — Jun 2018 [monthly]
Recruiting PHASE3
Status: Not Yet Recruiting → Recruiting
-
Aug 2017 — Nov 2017 [monthly]
Not Yet Recruiting PHASE3
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Kevin Hill
- National Center for Advancing Translational Sciences (NCATS)
For direct contact, visit the study record on ClinicalTrials.gov .